type
zbdillqhzh5
SyllabusSpring18.docxWALSH UNIVERSITY
|
Client’s Initials |
Age |
Room & Bed # |
Admission Date |
Psychiatric (DSM-5) Diagnosis |
Student |
Date Initiated |
Date Revised |
|
Pt. Diagnostic Statement (PES) (NANDA) |
Outcomes |
Interventions |
Rationale (with Source) Refer to Townsend or other psychiatric text |
Evaluation of Outcome Achievement |
|
|
|
|
|
|
Page_________
|
Pt. Diagnostic Statement (PES) |
Outcomes |
Interventions |
Rationale (with Source) |
Evaluation of Outcome Achievement |
|
|
|
|
|
|
2
c:\bsn\320\syllabus Sp01.doc-3/1/18
Client Initials _________Room # ______
WALSH UNIVERSITY
ALLERGIES ______________________ BYERS SCHOOL OF NURSING
MEDICATION FORM
|
GENERIC & TRADE NAME AND ACTION
|
REASON FOR PATIENT RECEIVING THIS DRUG |
CLIENT’S DOSAGE & ROUTE
recommended ordered |
SIDE EFFECTS |
NURSING IMPLICATIONS (INCLUDE RATE OF ADMINISTRATION IF APPLICABLE) |
TEACHING IMPLICATIONS |
|
|
|
|
|
|
|
|
|
Page
|
GENERIC & TRADE NAME AND ACTION
|
REASON FOR PATIENT RECEIVING THIS DRUG |
CLIENT’S DOSAGE & ROUTE
recommended ordered |
SIDE EFFECTS |
NURSING IMPLICATIONS (INCLUDE RATE OF ADMINISTRATION IF APPLICABLE) |
TEACHING IMPLICATIONS |
|
|
|
|
|
|
|
|
|
3
c:://bsn/320/sylla01.doc-3/1/18
